1
Arvidsson Folke Lars Erik: Therapeutically useful tetralin derivatives.. Arvidsson Folke Lars Erik, Carlsson Per Arvid Emil, Hacksell Uli A, Hjorth John Stephan Mikael, Lindberg Per Lennart, Nilsson John Lars Gunnar, Sanchez Domingo, Wikstrom Hakan Vilhelm, December 9, 1981: EP0041488-A1 (36 worldwide citation)

Compounds of the formula wherein Y is OCH3, OH, NH2, RCOO, RCONH or CH3SO2NH and R is an alkyl group having 1 to 5 carbon atoms, a benzyl or phenyl group, and R is an alkyl group having 1 to 8 carbon atoms, a benzyl or phenethyl group and R is hydrogen or an alkyl group having 1 to 5 carbon atoms or ...


2
Klaus Kunde, Karl Josef Herd: Process for the preparation of amino-substituted thioethers. Bayer Aktiengesellschaft, Sprung Horn Kramer & Woods, April 25, 1995: US05410081 (29 worldwide citation)

Compounds of the formula (I) ##STR1## are prepared by reacting 2-mercaptoethanol with compounds of the general formula (II) ##STR2## the substituents having the definition given in the description.


3

4
Stemerick David M, Bitonti Alan J, Edwards Michael J, Mccann Peter P, Sjoerdsma Albert: Novel polyamine derivatives.. Merrell Dow Pharma, August 10, 1988: EP0277635-A2 (24 worldwide citation)

This invention relates to certain polyamine derivatives, to the methods and intermediates useful for their preparation, and to their use in treating diseases caused by infestation with a variety of parasitic protozoa.


5
Ronald J McKinney: Ammonolysis of nylon. E I Du Pont de Nemours and Company, April 12, 1994: US05302756 (22 worldwide citation)

Useful monomeric products are obtained in the reaction of nylon 6,6 with ammonia. Increased yield of monomer products from nylon 6,6 is obtained from ammonolysis when a mixture with nylon 6 is employed.


6
Sun Jung Hui: Bis-naphthalimides containing amino-acid derived linkers as anticancer agents.. Du Pont Merck Pharma, September 30, 1992: EP0506008-A1 (19 worldwide citation)

This invention relates to bis-naphthalimides, including 2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]-bis[5-nitro-1 H-benz[de]isoquinoline-1,3(2H)-dione] and 2,2'-[1,2-ethanediylbis[imino(2-methyl-2,1-ethanediyl)]]-bis[5-nitro-1 H-benz[de]isoquinoline-1,3(2H)-dione], processes for their p ...


7
Bergeron Raymond J: Univ Florida, January 3, 1990: EP0349224-A2 (19 worldwide citation)

The present invention provides a compound having one of the formulae: Wherein: R1 and R6 may be the same or different and are H, alkyl or aralkyl having from 1 to 12 carbon atoms, provided that R1 and R6 are not H; R7 is H, alkyl, aryl or aralkyl having from 1 to 12 carbon atoms; m is an integer fro ...


8
Gold Elijah H, Babad Esther, Peer Lydia, Chang Wei K: Process for the preparation of a phenylalkylaminoethylsalicylamide.. Schering, November 2, 1983: EP0092787-A1 (18 worldwide citation)

There are disclosed a process for producing (-)-5-{(R)-1-hydroxy-2-[(R)-1-methyl-3-phenylpropyl]aminoethyl} salicylamide and its acid addition salts in high yields which does not require chromatography, and important intermediates in this process. The process is stereoselective for the desired (R,R) ...


9
Korbonits Dezso Dr, Kiss Pal Dr, Szekeres Laszlo Dr, Papp Gyula Dr, Kovacs Gabor Dr, Santa Geb Csutor Andrea, Virag Sandor Dr, Udvari Eva Dr, Bata Imre, Marmarosi Geb Kellner Katalin, Tardos Laszlo Dr, Kormoczy Peter Dr, Gergely Vera Dr, Vargai Zoltan Dr: Diphenylpropylamine derivatives, their preparation and their pharmaceutical use.. Chinoin Gyogyszer Es Vegyeszet, January 20, 1988: EP0253327-A2 (15 worldwide citation)

Diphenylpropylamine derivatives of the formula I in which: R denotes hydrogen or methyl, R denotes hydrogen, methyl or n-decyl, Z (a) denotes a phenyl group substituted by R, R and R, in which: R denotes hydrogen, fluorine, chlorine or bromine, nitro, C1-12-alkyl, C1-4-alkoxy, phenoxy or benzyloxy, ...


10
Li Hong Xin, Santiesteban Jose, Armor John Nelson: Triethylenediamine synthesis with base-treated zeolites as catalysts. Air Prod & Chem, March 25, 1998: EP0831096-A2 (14 worldwide citation)

A process for preparing triethylenediamine by passing an ethanolamine, ethyleneamine, piperazine or morpholine over a pentasil-type zeolite at elevated temperature characterized by employing a ZSM-5 zeolite in the hydrogen or ammonium form which has been pretreated with an aqueous caustic solution.



Click the thumbnails below to visualize the patent trend.